Squamous Bladder Cancer Treatment in Singapore

Squamous bladder cancer treatment encompasses medical and surgical interventions designed to eliminate cancer cells, prevent spread, and preserve bladder function when possible. Squamous cell carcinoma accounts for approximately 3 to 5 percent of bladder cancers in Singapore and requires different treatment approaches compared to transitional cell carcinoma.

Treatment involves a multimodal approach combining surgery, chemotherapy, and sometimes radiation therapy. The specific treatment plan depends on cancer stage, location within the bladder, and overall health status. Squamous bladder cancer often presents at a more progressed stage and may be associated with chronic bladder irritation or schistosomiasis in endemic regions.

The primary goal is complete cancer removal while maintaining quality of life. Treatment planning involves careful staging through imaging studies and cystoscopic evaluation to determine disease extent. Consulting a bladder specialist in Singapore supports personalised treatment planning, with MOH-accredited specialists collaborating to create strategies that address both the cancer and any underlying contributing conditions.

Ideal Candidates

• Patients with confirmed squamous cell carcinoma of the bladder through biopsy
• Individuals with localised or regional disease amenable to curative treatment
• Patients with adequate kidney function to tolerate chemotherapy if needed
• Those with sufficient overall health to undergo surgery when indicated
• Individuals able to comply with follow-up requirements and surveillance protocols
• Patients without contraindications to planned treatment modalities

Contraindications

• Severe kidney dysfunction preventing chemotherapy administration
• Progressed heart or lung disease precluding safe surgery
• Uncontrolled infections requiring resolution before treatment
• Bleeding disorders that increase surgical risks significantly
• Previous pelvic radiation that limits treatment options
• Metastatic disease requiring palliative rather than curative approaches

Treatment suitability requires comprehensive evaluation by a multidisciplinary team. Your MOH-accredited urologist will assess your specific situation, considering cancer characteristics and overall health status. Age alone does not preclude treatment, as physiological fitness matters more than chronological age. Some patients benefit from optimisation of other medical conditions before proceeding with definitive cancer treatment.

Transurethral Resection of Bladder Tumour (TURBT)

TURBT serves as both a diagnostic and therapeutic procedure for squamous bladder cancer. Using a resectoscope inserted through the urethra, the urologist removes visible tumour tissue while obtaining samples for pathological analysis. This procedure determines invasion depth and guides subsequent treatment decisions. For early-stage tumours, TURBT may be curative, though squamous cell carcinoma often requires additional treatment due to its aggressive nature.

Radical Cystectomy

Radical cystectomy involves complete removal of the bladder along with surrounding lymph nodes and adjacent organs that may harbour cancer cells. In men, this includes the prostate and seminal vesicles; in women, the uterus, ovaries, and anterior vaginal wall may be removed. This procedure offers the chance of cure for muscle-invasive squamous bladder cancer. Modern surgical techniques, including robotic-assisted approaches, can reduce recovery time and complications while maintaining oncological effectiveness.

Systemic Chemotherapy

Chemotherapy plays a crucial role in treating squamous bladder cancer, either before surgery (neoadjuvant) or after surgery (adjuvant). Common regimens include cisplatin-based combinations that target rapidly dividing cancer cells throughout the body. Neoadjuvant chemotherapy can shrink tumours before surgery, potentially improving surgical outcomes. The specific chemotherapy protocol depends on kidney function, overall health, and disease extent.

Technology & Equipment Used

Modern treatment utilises technologies including high-definition cystoscopy systems for precise tumour visualisation, robotic surgical platforms for minimally invasive procedures, and contemporary chemotherapy delivery systems. Imaging technologies such as CT and MRI provide detailed staging information, while PET scans may detect distant spread. Pathology laboratories use immunohistochemistry techniques to confirm squamous differentiation and guide treatment selection.

Pre-Treatment Preparation

Before initiating treatment, comprehensive staging studies including CT scans of the chest, abdomen, and pelvis assess disease extent. Blood tests evaluate kidney function, liver function, and blood counts to ensure safety for planned treatments. Patients meet with specialists including urologists, medical oncologists, and anaesthesiologists to discuss the treatment plan. Nutritional assessment helps optimise physical condition before treatment. Smoking cessation improves treatment outcomes and reduces complications.

Patients requiring surgery undergo pre-operative preparation including bowel preparation if intestinal segments will be used for urinary diversion. Antibiotics may be prescribed to reduce infection risk. Those receiving chemotherapy require placement of a central venous catheter for medication administration. Fertility preservation options are discussed with patients of reproductive age, as treatments may affect fertility.

During the Procedure

For TURBT, spinal or general anaesthesia is administered before the procedure, which takes 30-60 minutes. The surgeon systematically removes all visible tumour and obtains samples from the tumour base and edges. Radical cystectomy requires general anaesthesia and takes 4-6 hours, including time for lymph node dissection and urinary diversion creation. The surgical team monitors vital signs continuously throughout.

Chemotherapy administration occurs in an outpatient infusion centre over several hours per session. Patients receive pre-medications to prevent nausea and allergic reactions. Vital signs and symptoms are monitored throughout the infusion. Treatment cycles occur every 3-4 weeks, allowing recovery between sessions.

Immediate Post-Treatment

Following TURBT, patients recover in the post-anaesthesia unit before discharge, usually the same day. A urinary catheter remains temporarily to allow bladder healing. After radical cystectomy, patients spend time in intensive care for close monitoring before transferring to a regular ward. Pain management, early mobilisation, and respiratory exercises begin immediately to prevent complications.

Chemotherapy patients are monitored for immediate reactions before discharge home. Anti-nausea medications and supportive care instructions are provided. Blood counts are checked regularly to monitor chemotherapy effects on bone marrow function.

First 24-48 Hours

After TURBT, mild blood in urine is normal and gradually clears. Pain is minimal and managed with oral medications. Patients should drink plenty of fluids to flush the bladder and prevent blood clot formation. Activity restrictions are minimal, though heavy lifting should be avoided.

Following radical cystectomy, patients remain hospitalised with careful monitoring of urine output through the new urinary diversion. Pain control through epidural or patient-controlled analgesia ensures comfort. Breathing exercises and leg movements prevent pneumonia and blood clots. The healthcare team monitors for signs of infection or complications.

First Week

TURBT patients can resume normal activities within days, though strenuous exercise should wait until bleeding stops. Follow-up appointments ensure proper healing and review pathology results. Patients learn to recognise warning signs such as persistent bleeding or urinary retention requiring medical attention.

Cystectomy patients gradually increase activity levels with physical therapy assistance. Dietary progression from liquids to solid foods occurs as bowel function returns. Patients and caregivers learn stoma care or catheter management depending on the urinary diversion type. Surgical drains are removed as output decreases.

Long-term Recovery

Complete recovery from radical cystectomy takes 6-8 weeks, with gradual return to normal activities. Patients adapt to their new urinary diversion with support from specialised nurses. Regular follow-up includes imaging studies and blood tests to monitor for recurrence. Chemotherapy patients require several months for blood counts to recover and energy levels to normalise.

Long-term surveillance involves regular cystoscopy (if bladder preserved), CT scans, and urine cytology. Patients learn to manage potential long-term effects such as changes in sexual function or urinary patterns. Support groups provide valuable peer connections during adjustment to life after treatment.

Effective treatment of squamous bladder cancer offers the opportunity for cure, particularly when diagnosed before distant spread occurs. Radical cystectomy provides definitive local control, eliminating the primary tumor source and reducing recurrence risk in the pelvis. Modern surgical techniques preserve sexual function in many patients while maintaining cancer control effectiveness.

Multimodal treatment combining surgery with chemotherapy improves survival rates compared to single-modality treatment. Neoadjuvant chemotherapy can downstage tumors, making complete surgical removal more achievable. For patients with localized disease, five-year survival rates following appropriate treatment are encouraging.

Quality of life considerations are integral to modern treatment approaches. Continent urinary diversions allow many patients to maintain normal voiding patterns without external appliances. Nerve-sparing surgical techniques help preserve sexual function when oncologically appropriate. Comprehensive rehabilitation programs help patients adapt successfully to physical changes while maintaining active lifestyles.

Consulting a urologist in Singapore ensures that treatment options are tailored to individual needs, supported by modern surgical methods and multidisciplinary expertise.

Common Side Effects

Temporary blood in urine following TURBT resolves within days to weeks. Bladder spasms and urgency may occur as the bladder heals from surgical trauma. Chemotherapy commonly causes fatigue, nausea, and temporary hair loss that resolve after treatment completion. Surgical patients experience temporary bowel dysfunction as intestinal function returns to normal.

Post-cystectomy patients may experience changes in sexual function, though this often improves with time and appropriate treatment. Urinary diversion requires adaptation, with initial challenges in management becoming routine with practice. Chemotherapy may cause temporary decreases in blood counts, requiring monitoring and occasionally treatment delays.

Rare Complications

Serious surgical complications including bleeding requiring transfusion, infection, or anastomotic leak occur in a small percentage of cases. These risks are minimised through meticulous surgical technique and appropriate patient selection. Chemotherapy rarely causes severe kidney dysfunction or hearing changes requiring treatment modification.

Long-term complications may include strictures at surgical connection sites requiring intervention, hernias at incision sites, or metabolic changes from intestinal urinary diversions. Regular follow-up allows early detection and management of these issues. The risk of complications decreases with surgeon experience and institutional volume.

Treatment costs for squamous bladder cancer vary significantly depending on stage at diagnosis and required interventions. Factors influencing cost include extent of surgery needed, number of chemotherapy cycles, length of hospitalisation, and complexity of reconstruction. Radical cystectomy with urinary diversion represents a major surgical procedure with associated facility, professional, and recovery costs.

The treatment package includes surgeon fees, anaesthesia services, operating room charges, hospitalisation costs, pathology services, and post-operative care. Chemotherapy costs depend on specific drugs used, number of cycles, and supportive medications required. Additional costs may include pre-treatment staging studies, specialised stoma supplies, and rehabilitation services.

Long-term follow-up and surveillance represent ongoing costs that should be considered in treatment planning. Our clinic provides detailed cost estimates during consultation, helping patients understand and plan for treatment expenses.